European Commission authorises fourth safe and effective vaccine against COVID-19

European Commission Press release Brussels, 11 Mar 2021 Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the fourth COVID-19 vaccine authorised in the EU.

Other news